Browsing by Subject "Cost-effectiveness analysis"
Now showing items 1-1 of 1
-
(Taylor and Francis Inc., 2015)© 2015 Taylor & Francis Group, LLC. NmenB vaccine (4CMenB) is now available, but studies on the cost-effectiveness of vaccine introduction in a country outbreak situation are lacking. The aim of this study was to evaluate ...